Concepedia

Bruce Beyer

BB

14

Publications

617

Citations

13

H-Index

1982

Active since

Affiliations

Sanofi (United States)(Current)

Environmental Protection Agency

Health and Environmental Sciences Institute

Pfizer (United States)

Bristol-Myers Squibb (United States)

Bruce Beyer is an author at Sanofi (United States) specializing in medicine, pharmacology, and public health.

Top concepts

Publications per year

1982–2019

14

Publications

14

Terminology of developmental abnormalities in common laboratory mammals (version 1)

L. David Wise, Sidney L. Beck, Diana Beltrame et al. · Teratology · 1997 · 170 citations · Full text

State of the art in developmental toxicity screening methods and a way forward: a meeting report addressing embryonic stem cells, whole embryo culture, and zebrafish

Robert E. Chapin, Karen Augustine‐Rauch, Bruce Beyer et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2008 · 79 citations · Full text

ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation

Bruce Beyer, Neil Chernoff, Bengt Danielsson et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2010 · 66 citations

Exposure‐Based Validation List for Developmental Toxicity Screening Assays

George P. Daston, Bruce Beyer, Edward W. Carney et al. · Birth Defects Research Part B Developmental and Reproductive Toxicology · 2014 · 57 citations · Full text

, , +14

A multi-institutional study benchmarking the zebrafish developmental assay for prediction of embryotoxic plasma concentrations from rat embryo–fetal development studies

Steven Cassar, Manon Beekhuijzen, Bruce Beyer et al. · Reproductive Toxicology · 2019 · 38 citations · Full text

Rows per page

1–5 of 14